OMS: Osteoporosis Management in Women Who Had a Fracture
Percentage with bisphosphonate OR DXA scan within 6 months post-fracture.
Measure description
Percentage with bisphosphonate OR DXA scan within 6 months post-fracture.
Eligible population
Women 67-85 with osteoporosis-related fracture
Performance drivers
Post-fracture treatment gap; Star measure.
Documentation & PA strategy
After fracture: DXA + osteoporosis Rx (alendronate, zoledronic acid, denosumab).
Why HEDIS matters for prior authorization
Health plans align prior authorization criteria with HEDIS measures: documenting your patient meets the HEDIS definition often streamlines or eliminates PA hurdles. For Medicare Advantage in particular, plans are heavily incentivized via Star Ratings to push members and providers toward measure compliance, which translates into faster approvals for measure-aligned services.
Frequently asked questions
What does HEDIS measure OMS measure?
Percentage with bisphosphonate OR DXA scan within 6 months post-fracture.
What drives performance on this measure?
Post-fracture treatment gap; Star measure.
How should clinicians document for this measure?
After fracture: DXA + osteoporosis Rx (alendronate, zoledronic acid, denosumab).
What is the eligible population?
Women 67-85 with osteoporosis-related fracture
Streamline OMS workflow with ApprovalHelp
ApprovalHelp automates clinical PA, appeals, and HEDIS-aligned documentation. no setup fee.
Get started →Contact: hello@approvalhelp.com